Search research articles
Contact Us
Filters
Showing results (1-10 of 105) with videos related to
Page
of 11
Sort By:
Endocrine-Related Cancer
|
March 25, 2014
The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors
Daniel E Johnson
Chinese Journal of Cancer
|
January 20, 2012
Targeting proliferation and survival pathways in head and neck cancer for therapeutic benefit
Daniel E Johnson
Advances in Enzyme Regulation
|
December 25, 2007
Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis
Daniel E Johnson
Biomolecules
|
March 28, 2025
Triggering Pyroptosis in Cancer
Daniel E Johnson, Zhibin Cui
Biochemistry
|
July 24, 2002
Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death
Sanjeev Shangary, Daniel E Johnson
Cancer Letters
|
October 14, 2011
Bortezomib induces autophagy in head and neck squamous cell carcinoma cells via JNK activation
Changyou Li, Daniel E Johnson
Cell Cycle (Georgetown, Tex.)
|
February 21, 2013
Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest
Changyou Li, Daniel E Johnson
Cancer Prevention Research (Philadelphia, Pa.)
|
August 20, 2017
When the Damage Is Done: Selecting Patients for Head and Neck Cancer Chemoprevention Trials
Daniel E Johnson, Julie E Bauman
Advances in Biological Regulation
|
October 26, 2017
Signaling by cell surface death receptors: Alterations in head and neck cancer
Brandon C Leonard, Daniel E Johnson
Blood Reviews
|
January 30, 2015
An ATRActive future for differentiation therapy in AML
Daniel E Johnson, Robert L Redner
Page
of 11
Search research articles
Search
Showing results (1-10 of 105) with videos related to
Sort By:
Page
of 11
Endocrine-Related Cancer
|
March 25, 2014
The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors
Daniel E Johnson
Chinese Journal of Cancer
|
January 20, 2012
Targeting proliferation and survival pathways in head and neck cancer for therapeutic benefit
Daniel E Johnson
Advances in Enzyme Regulation
|
December 25, 2007
Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis
Daniel E Johnson
Biomolecules
|
March 28, 2025
Triggering Pyroptosis in Cancer
Daniel E Johnson, Zhibin Cui
Biochemistry
|
July 24, 2002
Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death
Sanjeev Shangary, Daniel E Johnson
Cancer Letters
|
October 14, 2011
Bortezomib induces autophagy in head and neck squamous cell carcinoma cells via JNK activation
Changyou Li, Daniel E Johnson
Cell Cycle (Georgetown, Tex.)
|
February 21, 2013
Liberation of functional p53 by proteasome inhibition in human papilloma virus-positive head and neck squamous cell carcinoma cells promotes apoptosis and cell cycle arrest
Changyou Li, Daniel E Johnson
Cancer Prevention Research (Philadelphia, Pa.)
|
August 20, 2017
When the Damage Is Done: Selecting Patients for Head and Neck Cancer Chemoprevention Trials
Daniel E Johnson, Julie E Bauman
Advances in Biological Regulation
|
October 26, 2017
Signaling by cell surface death receptors: Alterations in head and neck cancer
Brandon C Leonard, Daniel E Johnson
Blood Reviews
|
January 30, 2015
An ATRActive future for differentiation therapy in AML
Daniel E Johnson, Robert L Redner
Page
of 11